Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation Through Activating Pparalpha Pathway.
Curr Mol Med. 2018;18(10):698-710. doi: 10.2174/1566524019666190207143207.
Curr Mol Med. 2018.
PMID: 30734676
Free PMC article.
BACKGROUNDS: We recently reported that Naoxintong (NXT), a China Food and Drug Administration (FDA)-approved cardiac medicine, could reduce the plaque size, but the underlying mechanism remains elusive now. ...METHOD: THP-1 cells and bone marrow-derived macrophages were in …
BACKGROUNDS: We recently reported that Naoxintong (NXT), a China Food and Drug Administration (FDA)-approved cardiac medicine, could …